Some benefits, such as improved skin tone and enhanced immunity, develop progressively with regular sessions
Aleniglipron showed 11.3% placebo-adjusted weight loss at 120 mg in the Phase 2b ACCESS study (36 weeks), with a higher exploratory dose reaching 15.3%
Patients with chronic heartburn, especially those on medications that affect gastrointestinal motility like semaglutide, should be monitored for signs of Barretts esophagus through regular endoscopic examinations
People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not take it
If a certificate of analysis or batch-specific document is available, researchers should keep it with the study file and cross-check product identity, purity, appearance, and lot details before use
International orders may incur customs charges or additional taxes